Back
Voyager Therapeutics Vs. Bowman Consulting Group Industry Stock Comparison
Sell
44
VYGR
Voyager Therapeutics
Last Price:
7.62
Seasonality Move:
1.94%
Sell
38
BWMN
Bowman Consulting Group
Last Price:
32.87
Seasonality Move:
-5.05%
Sell
44
Voyager Therapeutics (VYGR)
is a Sell
Is Voyager Therapeutics a Buy, Sell or Hold?
- The current Voyager Therapeutics [VYGR] share price is $7.62. The Score for VYGR is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- VYGR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Bowman Consulting Group (BWMN)
is a Sell
Is Bowman Consulting Group a Buy, Sell or Hold?
- The current Bowman Consulting Group [BWMN] share price is $32.95. The Score for BWMN is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- BWMN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VYGR Stock Price Chart
What is Voyager Therapeutics's stock price today?
-
The Voyager Therapeutics share price today is $7.62
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VYGR is experiencing buying pressure, which is a positive indicator for future bullish movement.
BWMN Stock Price Chart
What is Bowman Consulting Group's stock price today?
-
The Bowman Consulting Group share price today is $32.95
The current trend is relatively stagnant and BWMN is experiencing buying pressure, which is a positive indicator for future bullish movement.
VYGR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.44 | Sell |
| Relative Strength Index (14 RSI): | 38.28 | Sell |
| Chaikin Money Flow: | 185632 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.76 - 9.56) | Sell |
| Bollinger Bands (100): | (7.46 - 9.26) | Sell |
BWMN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.97 | Sell |
| Relative Strength Index (14 RSI): | 50.62 | Buy |
| Chaikin Money Flow: | 64449 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (30.15 - 35.93) | Sell |
| Bollinger Bands (100): | (30.95 - 36.57) | Sell |
VYGR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.58 | Buy |
| 20-day SMA: | 8.46 | Sell |
| 50-day SMA: | 8.77 | Sell |
| 200-day SMA: | 8.22 | Sell |
| 8-day EMA: | 7.7 | Sell |
| 20-day EMA: | 8.2 | Sell |
| 50-day EMA: | 8.47 | Sell |
| 200-day EMA: | 8.32 | Sell |
BWMN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 31.17 | Buy |
| 20-day SMA: | 31.78 | Buy |
| 50-day SMA: | 34.47 | Sell |
| 200-day SMA: | 31.57 | Buy |
| 8-day EMA: | 31.73 | Buy |
| 20-day EMA: | 32.39 | Buy |
| 50-day EMA: | 33.47 | Sell |
| 200-day EMA: | 31.57 | Buy |
Voyager Therapeutics Earnings Growth & VYGR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.11 per share, a decrease this year of $3.25 per share, and an increase next year of $0.04 per share.
Bowman Consulting Group Earnings Growth & BWMN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.37 per share, a decrease next quarter of $0.14 per share, an increase this year of $0.61 per share, and an increase next year of $0.38 per share.
Voyager Therapeutics Technical Analysis
| Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bowman Consulting Group Technical Analysis
| Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||